Tiedemann Advisors, LLC Fibrogen Inc Transaction History

Tiedemann Advisors, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 12, 2020	SELL	$34.58 - $48.06 $522,987 - $726,859	-15,124 Closed	0 $0
Q3 2019 Nov 06, 2019	BUY	$36.98 - $48.45 $3,661 - $4,796	99 Added 0.66%	15,124 $560,000
Q3 2017 Nov 13, 2017	BUY	$33.4 - $53.9 $209,818 - $338,599	6,282 Added 71.85%	15,025 $808,000
Q2 2017 Aug 14, 2017	BUY	N/A	8,743	8,743 $1.9 Million

47.1M

387K

672K

Ticker FGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 93,741,200
Market Cap $46.9M
Description
FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. The company is developing Roxadustat, an oral small molecule inhibitor of hypoxia inducible factor prolyl hydroxylases, which has completed Phase III clinical development for the treatment of anemia in chronic k...

Get notified when there are updates to the investment portfolio of Tiedemann Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Tiedemann Advisors, LLC with notifications on news.